Zobrazeno 1 - 10
of 14
pro vyhledávání: '"E. M. Mamizhev"'
Autor:
A. K. Nosov, E. M. Mamizhev, A. V. Vorobyev, O. B. Zhukov, A. I. Novikov, R. D. Zassev, I. A. Korneev, S. B. Petrov
Publikováno v:
Андрология и генитальная хирургия, Vol 18, Iss 1, Pp 28-38 (2017)
Malignant tumors of the testicle comprise about 1–2 % of all neoplasms in males and 5 % of tumors of the urinary system and male genitals. At early stages, malignant tumors of the testicle have no clinical manifestations. Gradually increasing in si
Externí odkaz:
https://doaj.org/article/30e0c52d002449e2b5250d8c05e7203a
Autor:
E. M. Mamizhev, T. Kh. Kemryugov, B. I. Aslanov, D. V. Nekrasov, O. V. Lavrinovich, D. I. Rumyantseva, A. K. Nosov
Publikováno v:
Cancer Urology. 19:115-128
Survival rates for cancer patients continue to steadily increase due to improvement of effectiveness of current treatments. However, despite significant oncological results, one should not forget about the quality of life of this cohort of patients,
Autor:
A. K. Nosov, M. V. Berkut, E. M. Mamizhev, T. Yu. Galunova, D. I. Rumyantseva, D. P. Semeyko, S. A. Reva, S. Yu. Konyashkina
Publikováno v:
Creative surgery and oncology. 13:13-20
Introduction. The key treatment for high-risk non-invasive bladder tumor or invasive urothelial cancer remains radical cystectomy (RCE), which provides the best survival rates. At the same time, the incidence of infectious complications in a number o
Autor:
A. K. Nosov, E. M. Mamizhev, N. A. Shchekuteev, D. P. Semeyko, P. A. Lushina, D. I. Rumyantseva, M. V. Berkut
Publikováno v:
Cancer Urology. 18:27-34
Background. The kidney cancer treatment remains cornerstone problem in our country for healthcare. Survival results of partial nephrectomy as a radical nephrectomy are similar in groups of patients with the same morphological features and was confirm
Autor:
A. K. Nosov, E. M. Mamizhev, B. I. Aslanov, R. I. Ryabinin, Kh. N. Bayramov, D. I. Rumyantseva, M. V. Berkut, D. V. Nekrasov
Publikováno v:
Cancer Urology. 18:26-37
Objective. Radical nephrectomy with thrombectomy of the inferior vena cava is the preferred treatment for renal cell carcinoma with an tumor thrombosis. We describe our experience and presentreview of the literature evaluating the feasibility and saf
Autor:
A. K. Nosov, D. I. Rumyantseva, E. M. Mamizhev, P. A. Lushina, N. A. Shchekuteev, M. V. Berkut
Publikováno v:
Cancer Urology. 18:127-135
The ureter is a unique tubular structure, extremely sensitive to exogenous influences and directly affects to renal function. The injuries of the ureter remain one of the most difficult problems requiring an extraordinary surgical approach in urology
Autor:
E. M. Mamizhev, I. B. Dzhalilov, B. I. Aslanov, T. Kh. Kemryugov, S. S. Krestianinov, V. K. Osetnik, A. A. Kharsov
Publikováno v:
Onkourologiâ, Vol 16, Iss 3, Pp 205-208 (2020)
Patients who practice Islam often refuse the proposed type of treatment for malignant neoplasms, citing religious reasons. Most fear that complete or partial non-retention of urine, the presence of a urostoma (ileal conduit) will violate their ritual
Autor:
I. B. Dzhalilov, V. K. Osetnik, E. M. Mamizhev, E. V. Parshina, S. S. Krestyaninov, M. A. Alekseev, R. V. Orlova
Publikováno v:
Onkourologiâ, Vol 16, Iss 2, Pp 36-43 (2020)
Background. Minimally invasive partial nephrectomy is the gold standard in the treatment of stage I malignant tumors. To date, there are a large number of techniques for performing partial nephrectomy. The desire to develop a technique that included
Publikováno v:
Onkourologiâ, Vol 16, Iss 1, Pp 106-113 (2020)
In the literature review we described studies, the main purpose of which was to distribute bladder tumors by molecular subtypes. A similar classification has long been actively used in the treatment of breast cancer. The pioneering work in the molecu
Autor:
E. M. Mamizhev, V. K. Osetnik, I. B. Dzalilov, B. I. Aslanov, A. S. Artemyeva, A. K. Nosov, Sh. Sh. Gadaev
Publikováno v:
Onkourologiâ, Vol 15, Iss 4, Pp 108-112 (2020)
Testicular tumors occur in 1–1.5 % of cases in the structure of the general oncological morbidity among men and constitute 5 % among tumors of the urogenital tract. In Western Europe, 3–6 new cases are recorded a year per 100 thousand male popula